Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanpeng Wu

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|April 30, 2025
Measles Population Immunity in Hunan, China: A Serological AssessmentYanpeng Wu, Qianli Wang, Wei Wang, et al.
China CDC Weekly|February 13, 2023
Transmission Dynamics and Epidemiological Characteristics of the SARS-CoV-2 Delta Variant - Hunan Province, China, 2021Kaiwei Luo, Yanpeng Wu, Yan Wang, et al.
Emerging Microbes & Infections|January 16, 2023
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in ShanghaiQianhui Wu, Hongyu Wang, Jianpeng Cai, et al.
Vaccines|June 27, 2025
Comparative Analysis of Long-Term Measles Immune Response After Natural Infection and Routine Vaccination in ChinaSihong Zhao, Qianli Wang, Juan Yang, et al.
China CDC Weekly|April 3, 2023
A Retrospective Modeling Study of the Targeted Non-Pharmaceutical Interventions During the Xinfadi Outbreak in the Early Stage of the COVID-19 Pandemic - Beijing, China, 2020Yan Wang, Kaiyuan Sun, Yang Pan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 20, 2022
SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in BeijingYan Wang, Kaiyuan Sun, Yang Pan, et al.
International Journal of Cancer|June 26, 2026
Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and SafetyLei Mao, Yumiao Mai, Suying Lu, et al.
Frontiers in Immunology|June 26, 2023
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in ChinaYe Hong, Mengjia Song, Yingxia Lan, et al.
Cancer Medicine|May 15, 2023
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysisJunting Huang, Suying Lu, Juan Wang, et al.
Frontiers in Pharmacology|August 1, 2024
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II studyJunting Huang, Jia Zhu, Lian Jiang, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|April 30, 2025
Measles Population Immunity in Hunan, China: A Serological AssessmentYanpeng Wu, Qianli Wang, Wei Wang, et al.
China CDC Weekly|February 13, 2023
Transmission Dynamics and Epidemiological Characteristics of the SARS-CoV-2 Delta Variant - Hunan Province, China, 2021Kaiwei Luo, Yanpeng Wu, Yan Wang, et al.
Emerging Microbes & Infections|January 16, 2023
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in ShanghaiQianhui Wu, Hongyu Wang, Jianpeng Cai, et al.
Vaccines|June 27, 2025
Comparative Analysis of Long-Term Measles Immune Response After Natural Infection and Routine Vaccination in ChinaSihong Zhao, Qianli Wang, Juan Yang, et al.
China CDC Weekly|April 3, 2023
A Retrospective Modeling Study of the Targeted Non-Pharmaceutical Interventions During the Xinfadi Outbreak in the Early Stage of the COVID-19 Pandemic - Beijing, China, 2020Yan Wang, Kaiyuan Sun, Yang Pan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 20, 2022
SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in BeijingYan Wang, Kaiyuan Sun, Yang Pan, et al.
International Journal of Cancer|June 26, 2026
Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and SafetyLei Mao, Yumiao Mai, Suying Lu, et al.
Frontiers in Immunology|June 26, 2023
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in ChinaYe Hong, Mengjia Song, Yingxia Lan, et al.
Cancer Medicine|May 15, 2023
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysisJunting Huang, Suying Lu, Juan Wang, et al.
Frontiers in Pharmacology|August 1, 2024
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II studyJunting Huang, Jia Zhu, Lian Jiang, et al.
Pageof 5